Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP253998.RACJSMl4upEhQGwAhqm5bIj7NNeAwC66McXam5y7fZ608130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP253998.RACJSMl4upEhQGwAhqm5bIj7NNeAwC66McXam5y7fZ608130_assertion type Assertion NP253998.RACJSMl4upEhQGwAhqm5bIj7NNeAwC66McXam5y7fZ608130_head.
- NP253998.RACJSMl4upEhQGwAhqm5bIj7NNeAwC66McXam5y7fZ608130_assertion description "[Since the Bayer preparation is no longer available for treatment of large series of patients with ALL, the present study was designed to prospectively evaluate coagulation and fibrinolytic changes in leukaemic children receiving different doses of Medac ASP, which is now available for treatment of childhood ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP253998.RACJSMl4upEhQGwAhqm5bIj7NNeAwC66McXam5y7fZ608130_provenance.
- NP253998.RACJSMl4upEhQGwAhqm5bIj7NNeAwC66McXam5y7fZ608130_assertion evidence source_evidence_literature NP253998.RACJSMl4upEhQGwAhqm5bIj7NNeAwC66McXam5y7fZ608130_provenance.
- NP253998.RACJSMl4upEhQGwAhqm5bIj7NNeAwC66McXam5y7fZ608130_assertion SIO_000772 8857948 NP253998.RACJSMl4upEhQGwAhqm5bIj7NNeAwC66McXam5y7fZ608130_provenance.
- NP253998.RACJSMl4upEhQGwAhqm5bIj7NNeAwC66McXam5y7fZ608130_assertion wasDerivedFrom befree-20150227 NP253998.RACJSMl4upEhQGwAhqm5bIj7NNeAwC66McXam5y7fZ608130_provenance.
- NP253998.RACJSMl4upEhQGwAhqm5bIj7NNeAwC66McXam5y7fZ608130_assertion wasGeneratedBy ECO_0000203 NP253998.RACJSMl4upEhQGwAhqm5bIj7NNeAwC66McXam5y7fZ608130_provenance.